105 related articles for article (PubMed ID: 36106)
1. [In vitro method for estimation of enteral absorption of clanobutin and other drugs].
Klemm K; Krüger U
Arzneimittelforschung; 1979; 29(1):2-11. PubMed ID: 36106
[TBL] [Abstract][Full Text] [Related]
2. Absorption of 14C-clanobutin-Na isolated perfused intestinal segments in vitro of rats.
Strugala G; Overhoff H; Forth W
Arzneimittelforschung; 1981; 31(3):429-33. PubMed ID: 7194668
[TBL] [Abstract][Full Text] [Related]
3. An in vitro collodion-lipid membrane model for drug absorption studies.
Brandys J; Kwiek J; Witek J
Pol J Pharmacol Pharm; 1974; 26(5):519-26. PubMed ID: 4427813
[No Abstract] [Full Text] [Related]
4. [Synthesis and physico-chemical parameters of clanobutin (author's transl)].
Klemm K; Krastinat W; Krüger U
Arzneimittelforschung; 1979; 29(1):1-2. PubMed ID: 582102
[TBL] [Abstract][Full Text] [Related]
5. A general approach for the prediction of the intestinal absorption of drugs: regression analysis using the physicochemical properties and drug-membrane electrostatic interaction.
Sugawara M; Takekuma Y; Yamada H; Kobayashi M; Iseki K; Miyazaki K
J Pharm Sci; 1998 Aug; 87(8):960-6. PubMed ID: 9687340
[TBL] [Abstract][Full Text] [Related]
6. Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition model.
Fliszar KA; Hill BT; Foster N
J Pharm Sci; 2007 Aug; 96(8):2161-70. PubMed ID: 17387695
[TBL] [Abstract][Full Text] [Related]
7. A new in vitro system for evaluation of passive intestinal drug absorption: establishment of a double artificial membrane permeation assay.
Kataoka M; Tsuneishi S; Maeda Y; Masaoka Y; Sakuma S; Yamashita S
Eur J Pharm Biopharm; 2014 Nov; 88(3):840-6. PubMed ID: 25304077
[TBL] [Abstract][Full Text] [Related]
8. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
Akamatsu M; Fujikawa M; Nakao K; Shimizu R
Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
[TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of pharmacokinetic drug interactions. 2: Interaction mechanisms during absorption].
Heydel E; Box A; Fürtig W
Pharmazie; 1984 Feb; 39(2):129-36. PubMed ID: 6371841
[No Abstract] [Full Text] [Related]
10. Relationship between the dipole moment and rate of absorption of drugs.
Past T; Tapsonyi Z; Hortobágyi I
Acta Med Acad Sci Hung; 1979; 36(1):137-47. PubMed ID: 43063
[TBL] [Abstract][Full Text] [Related]
11. Black lipid membranes as a model for intestinal absorption of drugs.
Inui KI; Tabara K; Hori R; Kaneda A; Muranishi S
J Pharm Pharmacol; 1977 Jan; 29(1):22-6. PubMed ID: 13177
[TBL] [Abstract][Full Text] [Related]
12. Absorption of 14C-clanobutin-Na in blood-perfused tied-off jejunal segments in vivo of rats.
Overhoff H; Strugala G; Forth W
Arzneimittelforschung; 1981; 31(4):670-4. PubMed ID: 7195713
[TBL] [Abstract][Full Text] [Related]
13. [Drug permeation through artificial lipoid membranes. 2. Mathematical description of substance transport].
Falk M; Fürst W
Pharmazie; 1973; 28(11):765-8. PubMed ID: 4791265
[No Abstract] [Full Text] [Related]
14. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
Usansky HH; Sinko PJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
[TBL] [Abstract][Full Text] [Related]
15. Lipophilicity and biological acitivity. Drug transport and drug distribution in model systems and in biological systems.
Kubinyi H
Arzneimittelforschung; 1979; 29(8):1067-80. PubMed ID: 40579
[TBL] [Abstract][Full Text] [Related]
16. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
[TBL] [Abstract][Full Text] [Related]
17. [Drug permeation through artificial lipid membranes. 17. The mechanism of ion pair transport].
Neubert R; Fürst W; Böhm W; Dabow S
Pharmazie; 1984 Jun; 39(6):401-3. PubMed ID: 6091156
[TBL] [Abstract][Full Text] [Related]
18. Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model.
Wagner C; Jantratid E; Kesisoglou F; Vertzoni M; Reppas C; B Dressman J
Eur J Pharm Biopharm; 2012 Sep; 82(1):127-38. PubMed ID: 22652546
[TBL] [Abstract][Full Text] [Related]
19. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
Varma MV; Panchagnula R
J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
[TBL] [Abstract][Full Text] [Related]
20. The composite solubility versus pH profile and its role in intestinal absorption prediction.
Hendriksen BA; Felix MV; Bolger MB
AAPS PharmSci; 2003; 5(1):E4. PubMed ID: 12713276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
